Cells treated with ibrutinib and acalabrutinib each had a unique set of 13 m/z signals, which opens up the possibility of studying these metabolites as biomarkers of therapeutic response.
Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...
15h
GlobalData on MSNAlzeCure Pharma secures €2.5m grant for Phase IIa trial of Alzheimer’s treatmentThe trial will explore the effects of higher doses of ACD856, building on the drug’s established safety profile.
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Colorectal cancer (CRC) is one of the most prevalent types of cancer and has a high mortality rate globally. Oral ...
The hangovers, the memory loss, and the guilt and remorse that accompanied mornings after drinking stuck me in a shame spiral.
Cells have surface receptors called integrins that bind to repetitive domains present on the extracellular matrix (ECM) surrounding the cells, allowing them to grow and spread. A new study from the ...
The virus is related to the pathogen that causes Middle East respiratory syndrome and capitalizes on the same ‘entry receptor ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
15h
GlobalData on MSNEC conditionally approves MSD’s Welireg for VHL disease and RCCThe EC has conditionally approved MSD's Welireg as a single agent for the treatment of adults with VHL disease and advanced ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results